Evaluating the clinical effects of GLP-1 receptor agonists for Alzheimer's and Parkinson's diseases using minimal clinically important difference: systematic review and meta-analysis.

Elghanam Y et al.

NCBI PubMed Central · Papers · License: Open Access

cognitive psychology

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 247461
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.